Text and Data Mining valid from 2019-02-22
Received: 2 November 2018
Accepted: 13 February 2019
First Online: 22 February 2019
Ethics approval and consent to participate
: This study involved de-identified, aggregate data and was not subject to Institutional Review Board approval at Emory University or the Centers for Disease Control and Prevention.
: Not applicable.
: BAL has received personal fees from Takeda Pharmaceuticals for service on their Norovirus Advisory Board outside the submitted work. JMB, RMD, JC and UDP have no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.